Cargando…
A New Medical Therapy for Multiple Endocrine Neoplasia Type 1?
Pancreatic neuroendocrine tumours (pNETs) are a major manifestation of multiple endocrine neoplasia type 1 (MEN1), and the most significant cause of morbidity and mortality in this disorder. There is some evidence that the early use of somatostatin analogues can retard progression, especially of sma...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Touch Medical Media
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838189/ https://www.ncbi.nlm.nih.gov/pubmed/36694894 http://dx.doi.org/10.17925/EE.2022.18.2.86 |